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Summary and Implications.
Previously reported studies have provided evidence
that ractopamine regulates the expression of skeletal α-
actin, but the molecular mechanisms underlying these
effects are poorly understood.  This was the first study to
look specifically at the effects of ractopamine on the
transcriptional regulation of a contractile protein in
myotube cultures.  Our model was sufficient to evaluate
the anabolic effects of ractopamine in porcine skeletal
muscle.  However, we were unable to identify a cis-acting
DNA element within the cloned porcine skeletal α-actin
promoter that conferred transcriptional responsiveness to
ractopamine in porcine skeletal muscle.  Thus, it appears
that ractopamine promotes the accumulation of skeletal α-
actin mRNA in porcine skeletal muscle via a post-
transcriptional mechanism.  Elucidation of the mechanism
whereby ractopamine increase skeletal muscle growth
will aid in the development of new strategies, both genetic
and pharmacological, to improve lean tissue deposition in
livestock species.
Introduction
Ractopamine, as well as other β-adrenergic agonists,
stimulate muscle hypertrophy in vivo. In porcine skeletal
muscle, ractopamine positively augments net protein
accretion, as fractional protein synthesis increases with no
apparent change in proteolysis.  Similarly, Skeletal α-
actin mRNA abundance in pigs and steers increases in
response to ractopamine, which indicates that the actin
promoter may be used as a reporter to understand the
mechanism whereby ractopamine regulates skeletal
muscle growth.
Materials and Methods.
Porcine satellite cells were isolated from three-week-
old gilts.  Briefly, hindlimb muscles (180 to 200 g) were
mechanically dissociated and digestion with bacterial
protease, followed by differential centrifugation.  Satellite
cells were then plated in growth media on culture dishes
coated with Matrigel and cultured standard cell culture
conditions.
At 85 to 90% confluence, satellite cells were
stimulated to differentiate into myotubes for 36 hours by
the addition of differentiation media. This regime
consistently produced cultures in which myotube nuclei,
defined as more than three nuclei per cell, accounted for
75.57 ± 3.31% of the total nuclei (or %fusion). Treatment
media consisted of Ractopamine (10 µM in H2O) or
volume equivalent vehicle control (H2O) in serum-free
differentiation media.
After 72 hours in treatment media, total RNA was
harvested with TRIzol reagent and used for first-strand
cDNA synthesis Quantitative PCR analysis was
conducted with a Smart Cycler (Cepheid, Sunnyvale, CA)
and SYBR Green I dye (Applied Biosystems, Foster City,
CA) in order to determine the relative expression levels of
skeletal α-actin and glyceraldehyde-3-phosphate
dehydrogenase (G3PDH) in primary porcine myotubes.
In order to evaluate the transcriptional regulation of
porcine skeletal α-actin we used a reporter construct that
contained 1929 bp of 5’ flanking sequence, the first exon
and 188 bp of the first intron fused to the reporter gene
luciferase. Transient transfection procedures were utilized
to introduce luciferase constructs into primary cell
cultures.  Transfected cells were stimulated to
differentiate and were treated with ractopamine (10 µM)
in serum-free media as described above.
Data was analyzed by one- or two-way analysis of
variance (ANOVA) with JMP software (Release 5.0,
2001; SAS Institute Inc., Cary, NC).  When main effects
were significant, least squared means (LSM) differences
were determined by Tukey’s HSD procedure, post hoc.
Least squared means and the standard error of the mean
are reported.  Comparisons were significantly different at
the level of P < 0.05.
Results.
After 72 hours in SFDM supplemented with
ractopamine, skeletal α-actin mRNA abundance increased
more than five-fold (5.374 ± 1.230 vs. 1.000 ± 0.1146; P
< 0.05) in porcine myotubes relative to untreated control
cultures (Figure 1).  In contrast, the skeletal α-actin
promoter was unresponsive to ractopamine (Figure 2).
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Figure 1. Detection of relative skeletal-α-actin mRNA in
ractopamine stimulated (_) and control (_) porcine
myotube cultures as determined by real-time quantitative
RT-PCR.  For skeletal α-actin, mRNA transcript
abundance was quantified by the comparative threshold
cycle (Ct) method as described in materials and methods.
Data represent lsmeans ± SEM relative to the control
mean.  Asterisk indicates a ractopamine effect (P < 0.05)
